Follow us on Twitter
twitter icon@FreshPatents


Functional Food patents

      

This page is updated frequently with new Functional Food-related patent applications.




 Refined plant isolates and process for the manufacture of a functional food ingredient from such plant isolate patent thumbnailRefined plant isolates and process for the manufacture of a functional food ingredient from such plant isolate
The present invention is concerned with providing refined plant isolates that can be used as starting materials for the production of functional food ingredients, such as taste enhancers, through an isolation process that employs ion exclusion chromatography. More particularly, the present invention provides a refined plant isolate comprising at least 30% by weight of dry matter of water soluble plant components selected from fructose, glucose, proteinaceous matter of plant origin, acids and potassium, said isolate further being characterized in that at a concentration of 40° brix the isolate: •contains at least 0.3 wt % of glutamate; •contains at least 500 ppm of k+; •contains less than 300 ppm of ca2+; •contains less than 700 ppm of mg2+; •contains less than 1 wt.
Conopco Inc., D/b/a Unilever


 Lactococcus lactis strains patent thumbnailLactococcus lactis strains
New lactococcus lactis strains, nrrl b-50571 and nrrl b-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower ldl-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation..
Centro De Investigación En Alimentación Y Desarrollo, A.c. (ciad)


 Lactococcus lactis strains patent thumbnailLactococcus lactis strains
New lactococcus lactis strains, nrrl b-50571 and nrrl b-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower ldl-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation..
Centro De Investigación En Alimentacion Y Desarrollo, A.c. (ciad)


 Enhanced herb or food product and method patent thumbnailEnhanced herb or food product and method
The present invention is a method of preparing and potentiating functional foods and, in particular, herbs by subjecting the food or herb to specific method steps, either a particular three- or four-step potentiating process or a specific infusion/fermentation potentiating technique, for which in some embodiments the fermentation is optional.. .
Get Real Holdings, Llc


 Functional food formula analysis system for personalized body weight management patent thumbnailFunctional food formula analysis system for personalized body weight management
A functional food formula analysis system for personalized body weight management includes a user input unit, a body constitution analysis data unit, a functional food data unit, an analysis server unit, and an analysis result storage unit. The analysis server unit is connected to the other units and is configured for retrieving personal data, personal genetic data, and obesity-associated body constitution data and performing data comparison, exchange, and integration on those data in order to output a personalized functional food formula report to be stored in the analysis result storage unit.
Union Applied Gene Inc.


 Use of derivatives of polyunsaturated fatty acids as medicaments patent thumbnailUse of derivatives of polyunsaturated fatty acids as medicaments
Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids.
Lipopharma Therapeutics, S.l.


 Pegylated 7-dehydrocholesterol derivatives patent thumbnailPegylated 7-dehydrocholesterol derivatives
The present invention relates to pegylated 7-dehydrocholesterol derivatives, and a composition for wrinkle alleviation and anti-aging comprising the same. The pegylated 7-dehydrocholesterol derivatives according to the present invention have improved stability and solubility in water, and thus can be effectively used as a good source for supplying vitamin d in a cosmetic composition, a pharmaceutical composition and a functional food for wrinkle alleviation and anti-aging..
Humedix Co., Ltd.


 Compositions and methods for preventing and treating diseases and environmentally induced health disorders patent thumbnailCompositions and methods for preventing and treating diseases and environmentally induced health disorders
Nutraceutical or pharmaceutical compositions, functional foods, extracts, dietary supplements and food/feed additives enriched in phytochemicals having antioxidant and/or anti-inflammatory activity may be derived from the skin, pith, or cortex from stem tubers of select potato cultivars, such as onaway, russet burbank, purple valley or bora valley cultivars. These cultivars and combinations thereof provide a useful antioxidant source enriched in ferulic acid, caffeic acid, chlorogenic acids, ascorbic acid, anthocyanins, and rutin, isomers or derivatives thereof having antioxidant and/or anti-inflammatory activity..
The Royal Institution For The Advancement Of Learning/mcgill University


 Processes for the preparation of phospholipid-enriched dairy products as neutraceuticals for the formulation of functional foods patent thumbnailProcesses for the preparation of phospholipid-enriched dairy products as neutraceuticals for the formulation of functional foods
The present invention discloses processes for the preparation of phospholipid-enriched dairy products as nutraceuticals for the formulation of functional foods, the processes include the steps of: combining a non-dairy-based pl-containing material, having phosphatidylserine (ps) and/or phosphatidic acid (pa) in the pl-containing material, wherein the ps and/or pa is derived in part from an enzymatically-processed lecithin as a ps-calcium and/or -magnesium salt and/or a pa-calcium and/or -magnesium salt via transphosphatidylation with phospholipase d in the presence of l-serine and a calcium and/or magnesium salt, with water and an oil component to form a paste; removing an excess amount of the water from the paste to form a pl-oil solution; and mixing the pl-oil solution with a dairy component, thereby obtaining a pl-enriched dairy product. Alternatively, the pl-oil solution has a weight-to-weight (w-w) concentration of at least about 0.01% of a residual amount of the water to the pl-containing material..
Lipogen Ltd.


 Process for drying and powderizing functional foods, nutraceuticals, and natural health ingredients patent thumbnailProcess for drying and powderizing functional foods, nutraceuticals, and natural health ingredients
A system for producing free-flowing powder with a narrow particle size distribution from liquid compositions comprising in combination: a feeding reservoir comprising said liquid compositions: a pumping device to pump said liquid composition into at least one atomizing device: said at least one atomizing device composed of at least one fluid nozzle to distribute an upward gaseous drying medium over said nozzle: two lateral streamlined tube-like devices for supplying said liquid composition and pressurized gas to said at least one nozzle from two opposite directions: a cylindrical plenum chamber wherein the fluid nozzle is located: an accelerating zone of a drying medium consisting of a cylindrical pipe located at the bottom of the cylindrical plenum: a conical-cylindrical drying chamber equipped with a manhole, a multi-nozzle manifold and insulation panels: and an intermediate drying medium consisting of a single bed or multi-beds of inert carriers within the drying chamber.. .
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Natural Resources


Bean leaves or bean stems having high isoflavone derivatives content and preparing same

The present invention relates to soybean leaves or soybean stems having high isoflavone derivative content, and a method for preparing the same. Specifically, by finding that soybean leaves or soybean stems treated with ethylene and ethephon, i.e.
Industry-academic Cooperation Foundation Gyeongsang National University

Novel fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same

The present invention relates to a fat accumulation inhibitory peptide which essentially comprises an amino acid sequence represented by seq id no: 1, a pharmaceutical composition for preventing or treating obesity, which contains the peptide, and a health functional food for preventing or alleviating obesity, which contains the peptide. The fat accumulation inhibitory peptide according to the present invention has the function of inhibiting the differentiation of mesenchymal stem cells into adipocytes to thereby inhibit the accumulation of adipose tissue.
Nano Intelligent Biomedical Engineering Corporation Co. Ltd.

Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states

Described herein are compositions including at least one omega-3 fatty acid (either in the triglyceride, ester or free fatty acid ester form) and at least one surface active agent; wherein the compositions form micelles when in contact with an aqueous medium. Also provided are methods of administering to a subject a composition including at least one omega-3 fatty acid (either in the triglyceride, ester or free fatty acid ester form) and at least one surface active agent, wherein the compositions form micelles when in contact with an aqueous medium, and the bioavailability of the omega-3 fatty acid is substantially independent of a food effect.
Sancilio & Company, Inc.

Ror gamma modulators

The present invention relates to compounds of formula i, or a pharmaceutically acceptable salt thereof, characterized in that at least one of r8, r9, r10, r11 is —ora; for use in the treatment or prevention, suppression or amelioration of a disease mediated, by the ror gamma receptor in a subject in need thereof, in particular diabetes and diabetes-related disorders, specifically type ii diabetes, methods of their production, their use as a dietary supplement or functional food, as well as methods of treatment or prevention of such diseases.. .
Eth ZÜrich

Composition for promoting differentiation or proliferation of erythrocytic cells, containing monoacetyl diacylglycerol compound as active ingredient

The present invention relates to compositions for promoting differentiation or proliferation of erythrocytic cells containing a monoacetyl diacylglycerol compound as an active ingredient, and pharmaceutical compositions and health functional food compositions for preventing, treating or alleviating erythrocytopenia containing the same. The monoacetyldiacylglycerol compound of the present invention is effective in promoting differentiation or proliferation of erythrocytic cells.
Korea Research Institute Of Bioscience And Biotech Nology

Composition comprising centipede grass extracts or fractions thereof as active ingredients

The present invention relates to a pharmaceutical composition for preventing or treating diabetes or dementia, comprising centipede grass (eremochloa ophiuroides) extracts as an active ingredient. It has been identified from animal tests that the centipede grass extracts, fractions thereof, and active fractions separated from the said fractions effectively regulate blood glucose levels, and inhibit the activity of amyloid-β(aβ) which is involved in the formation of amyloid plaques that might cause dementia.
Korea Atomic Energy Research Institute

Method for treating inflammatory, allergic or asthma diseases, containing paprika extracts

The present invention relates to a composition containing a paprika extract as an active ingredient, and more particularly to a pharmaceutical composition or health functional food for preventing or treating inflammatory, allergic or asthma disease, which contains a paprika extract. Particularly, paprika is a natural food which is readily available to anyone, and thus does not cause adverse effects even when it is taken for a long period of time..
Industry-university Cooperation Foundation Hanyang University

Composition for preventing or treating non-alcoholic liver disease or insulin resistance comprising ginsenoside f2

The present invention relates to a pharmaceutical composition, a health functional food, and a feed composition for the prevention, improvement, or treatment of non-alcoholic liver disease or insulin resistance comprising ginsenoside f2. The pharmaceutical composition according to the present invention comprising ginsenoside f2 can inhibit the adipogenesis and lipid accumulation in the liver, improve insulin sensitivity, inhibit the expression of inflammatory cytokines such as tnf-α, il-β, and il-6 in the kupffer cell, inhibit the expression of endocannabinoid synthase, thus capable of effectively preventing or treating non-alcoholic liver disease or insulin resistance..
Intelligent Synthetic Biology Center

Composition for preventing or treating stroke or neurodegenerative disease, comprising extract complex of pueraria lobata and scutellaria baicalensis as active ingredient

A composition, a health functional food or a treatment method of the present invention has a remarkable cranial nerve cell protection effect and simultaneously has a sensorimotor function recovery promotion effect and a body weight increasing effect. Accordingly, the present invention has effects of preventing stroke or neurodegenerative diseases, protecting cranial nerve cell cells over the mid to long term immediately after the onset of disease, promoting the recovery of a sensorimotor function reduced by stroke and neurodegenerative diseases, and increasing a reduced body weight.
University-industry Cooperation Group Of Kyung Hee University

Omega-3 fatty acid ester compositions

Compositions including at least one omega-3 fatty acid ester and at least one surface active agent are provided; wherein the compositions form micelles when in contact with an aqueous medium. Also provided is a method of administering to a subject such a composition, wherein the at least one omega-3 fatty acid ester forms micelles when in contact with an aqueous medium, and the bioavailability of the at least one omega-3 fatty acid ester is substantially independent of a food effect.
Sancilio & Company, Inc.

Lipid compositions

The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.. .
Aker Biomarine Antarctic As

Lipid extraction processes

The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.. .
Aker Biomarine Antarctic As

Composition containing lignan compound as active ingredient for preventing or treating cancer

Further, the present invention relates to a use of the lignan compound in the preparation of a pharmaceutical composition or a health functional food composition for preventing, ameliorating, or treating cancer.. .

Omega-3 fatty acid ester compositions

Compositions including at least one omega-3 fatty acid ester and at least one surface active agent are provided; wherein the compositions form micelles when in contact with an aqueous medium. Also provided is a method of administering to a subject such a composition, wherein the at least one omega-3 fatty acid ester forms micelles when in contact with an aqueous medium, and the bioavailability of the at least one omega-3 fatty acid ester is substantially independent of a food effect.
Sancilio & Company, Inc.

Omega-3 fatty acid ester compositions

Compositions including at least one omega-3 fatty acid ester and at least one surface active agent are provided; wherein the compositions form micelles when in contact with an aqueous medium. Also provided is a method of administering to a subject such a composition, wherein the at least one omega-3 fatty acid ester forms micelles when in contact with an aqueous medium, and the bioavailability of the at least one omega-3 fatty acid ester is substantially independent of a food effect.
Sancilio & Company, Inc.

Dietary composition containing cistanche deserticola polysaccharide with inhibitory effects on colon cancer

The present invention discloses the use of a cistanche deserticola polysaccharide in the preparation of functional food having efficacy of supplementary for inhibiting colon cancer, wherein cistanche deserticola polysaccharide is preferably prepared by the following method: with cistanche deserticola as raw material, is prepared by the processes including extraction with boiling water, deproteinization, dialysis and ethanol treatment, the cistanche deserticola polysaccharide has an effect of regulating tumor microenvironment, the cistanche deserticola polysaccharide according to the present invention is able to regulate tumor microenvironment by many pathways of inhibiting tumor angiogenesis, immunosuppression, anti-oxidation and inhibiting the growth of colon cancer fibroblast etc., which demonstrate that it has good effect of supplementary for inhibiting colon cancer tumor.. .

Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses

The invention relates to unique compositions containing enriched and purified natural crocin and/or crocetin for prevention and/or treatment of cancers and other conditions and diseases. Compositions comprise mainly enriched or purified natural crocin or crocetin or combination of both and possible other active phytochemicals.

Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis

The invention relates to pharmaceutical compositions, as well as health functional food compositions and quasi-drug compositions, for preventing, treating, or improving rheumatoid arthritis, comprising a monoacetyldiacylglycerol compound as an active ingredient. The monoacetyldiacylglycerol of the invention is effective in inhibiting the phosphorylation of stat-3 known to be a therapeutic target for rheumatoid arthritis.
Korea Research Institute Of Bioscience And Biotechnology

Hnf4-alpha antagonist and use thereof

Provided is a hepatocyte nuclear factor 4 alpha (hnf4-α) antagonist and a use thereof. The hnf4-α antagonist selected in the present invention was confirmed to specifically bind to the ligand binding domain of hnf4-α, thereby inhibiting the activity of hnf4-α.
National Cancer Center

Encapsulated functional food compositions

A functional food composition comprising an edible or potable substance, a cross-linked edible matrix encapsulating the edible or potable substance, a probiotic, and a prebiotic, with the proviso that the edible or potable substance and the matrix do not both contain the probiotic or both contain the prebiotic. The encapsulated composition provides certain advantages in its transport, handling and consumption.
Wikifoods, Inc.

Formulation and process for making fermented probiotic food and beverage products

A process providing a method for production of probiotic functional food products from plant substrates, the method comprising: activation of probiotic bacteria in an agar-agar formulation; formulation of water active plant substrates; culturing and incubation of water active plant substrates with activated probiotic bacteria; cooling and refrigeration.. .
University Of Central Oklahoma

Bioactive alkaloid compositions and their medical uses

The present invention relates to a novel alkaloid and novel bioactive alkaloid fractions derivable from ribes preferably selected among ribes rubrum and ribes nigrum; methods of manufacturing such bioactive ribes alkaloid fractions and their use for the inhibition of ikk-β, pde4 and/or pde5 and in addition their promoting effect on mitochondrial biogenesis and function; their therapeutic or non-therapeutic applications as nutritive or medicinal products in the management of conditions associated with impaired mitochondrial function or ikk-β, pde4 and/or pde5 activity, such as inflammation, neurodegeneration, dyslipidemia, type 2 diabetes mellitus, impaired wound healing, sarcopenia and other conditions associated with muscle dysfunction or tiredness and fatigue, or where optimization of muscular or cognitive function is desired; extracts, juices or concentrates of ribes comprising such alkaloids; compositions comprising such alkaloids, including pharmaceutical compositions, nutritive product such as functional foods and nutraceutical compositions, and cosmetic compositions and medical devices.. .

Method of treatment for enhancing exercise performance

Provided is a composition containing myricetin or a pharmaceutically available salt thereof as an active ingredient. The composition increases exercise capacity and enhances physical strength.

Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms

Described herein are compositions comprising at least one omega-3 fatty acid ester and at least one surface active agent; wherein the compositions form micelles when in contact with an aqueous medium. Also provided is a method of administering to a subject a composition comprising at least one omega-3 fatty acid ester and at least one surface active agent, wherein the at least one omega-3 fatty acid ester forms micelles when in contact with an aqueous medium, and the bioavailability of the at least one omega-3 fatty acid ester is substantially independent of a food effect.

Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis

The invention relates to pharmaceutical compositions, as well as health functional food compositions and quasi-drug compositions, for preventing, treating, or improving rheumatoid arthritis, comprising a monoacetyldiacylglycerol compound as an active ingredient. The monoacetyldiacylglycerol of the invention is effective in inhibiting the phosphorylation of stat-3 known to be a therapeutic target for rheumatoid arthritis.
Enzychem Lifesciences Corporation

Lactococcus lactis strains for producing bioactive peptides having anti-hypertensive and cholesterol-lowering effects

New lactococcus lactis strains, nrrl b-50571 and nrrl b-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower ldl-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation..
Centro De Investigación En Alimentación Y Desarrollo, A.c. (ciad)

Use of derivatives of polyunsaturated fatty acids as medicaments

Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids.
Lipopharma Therapeutics, S.l.

Use of derivatives of polyunsaturated fatty acids as medicaments

Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids.
Lipopharma Therapeutics, S.l.

Enteric-coated functional food ingredients and methods for making the enteric-coated functional food ingredients

functional food ingredients for delivery to the gastrointestinal tract are delivered. Food products, nutraceuticals, and pharmaceuticals comprising the functional food ingredients, as well as methods for making the functional food ingredients, are also provided.
Intercontinental Great Brands Llc

Agent or treatement and/or prevention of accelerated energy expenditure and/or diminished energy expenditure functionality

Disclosed herein is a solution that makes use of a food product that is effective for the detrimental decline of energy metabolism in humans and other mammals in need of treatment and/or prevention of accelerated energy expenditure and/or diminished energy expenditure functionality. The method disclosed herein continuously administers a functional food product rare sugar containing at least d-psicose to effectively improve energy expenditure..
Matsutani Chemical Industry Co., Ltd.

Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

The present invention is concerned with capsicum plants producing greater than about 0.4% zeaxanthin, by weight in the dried, ripe fruit pod flesh, which plants have been developed from commercially grown capsicum cultivars by plant breeding techniques. Zeaxanthin is the dominant carotenoid in the dried ripe fruit pod flesh, when measured in non-esterified forms.
Kalamazoo Holdings, Inc.

Pharmaceutical composition and health functional food containing red ginseng concentrate having enhanced compound k for preventing and treating non-alcoholic fatty liver disease

The present invention relates to a pharmaceutical composition and a health functional food composition for preventing and treating non-alcoholic fatty liver disease, which comprises red ginseng concentrate having enhanced compound k as an effective ingredient by using an enzyme conversion technique.. .
Cj Cheiljedang Corporation

Petroselinic acid or a combination of active ingredients comprising at least petroselinic acid for promoting weight loss and/or weight maintenance

The present invention relates to the field of weight management and obesity. It concerns petroselinic acid or a combination of active ingredients including at least petroselinic acid and at least one compound chosen from zinc, taurine, one of the salts of same, lycopene and the mixtures thereof, and preferably at least taurine or zinc gluconate and, more preferably still, at least taurine and zinc gluconate, as a drug for oral administration or as a functional food intended to promote weight loss and/or weight maintenance in a human being and/or animal, or indeed intended to fight obesity..

Ppar alpha/gamma dual agonist and its application

The present invention discloses a ppar α/γ dual agonist and its application. The ppar α/γ dual agonist comprises an effective amount of the compounds represented by formula i or/and its pharmaceutically acceptable derivative.
Shanghai University Of Traditional Chinese Medicine

Use of ginsenoside f2 for prophylaxis and treatment of liver disease

Provided are use of ginsenoside f2 in the prevention, improvement or treatment of liver disease, and a pharmaceutical composition, a health functional food, and a feed composition including ginsenoside f2. Ginsenoside f2 inhibits fat synthesis and accumulation in the liver, and increases distribution of regulatory t cells capable of inhibiting activity of inflammatory cells, thereby preventing hepatitis, and also increases expression of anti-inflammatory cytokine il-10 in regulatory t cells, and inhibits differentiation of naive t cells into th17 cells, and is thereby effectively used for the treatment of various liver diseases..
Intelligent Synthetic Biology Center

Resveratrol-enriched rice and the use there of

The present invention relates to resveratrol-enriched transgenic rice for biosynthesizing resveratrol at high concentration, in which resveratrol synthase genes are expressibly inserted into the 12th chromosome of natural rice, and seed of rice produced therefrom. Further, the present invention relates to a health functional food composition, an animal feed composition, and a pharmaceutical composition for preventing and improving a metabolic disease, including seed of rice produced from the resveratrol-enriched transgenic rice for biosynthesizing resveratrol, in which resveratrol synthase genes are expressibly inserted into the 12th chromosome of natural rice.
Republic Of Korea(management: Rural Development Administration

Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation

The present invention provides a use of a lipid composition for the preparation of a nutritional, pharmaceutical or nutraceutical composition or a functional food, for the prevention and treatment of gastrointestinal diseases and disorders, and for promoting intestinal development, maturation, adaptation and differentiation.. .
Enzymotec Ltd.

Use of microorganisms for the prevention and treatment of intestinal diseases

The invention relates to acetylcholine-producing microorganisms for use in the prevention and/or treatment of intestinal diseases, and/or reduction of risks of intestinal diseases, and/or improvement of intestinal health as well as promoting healthy gut flora. The acetylcholine-producing microorganisms may be provided as a pharmaceutical dosage form or as additive to functional food or food supplemental products.
Ludwig Stocker Hofpfisterei Gmbh

Bioactive compositions from theacea plants and use thereof in beverages, functional foods, nutriceuticals, supplements and the like

The present invention relates to isolated bioactive compositions containing bioactive fractions derived from theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions.
Akzo Nobel Chemicals International B.v.

Non-dairy formulae

The present invention is directed to non-dairy almond based formulae for the preparation of infant or toddler formula or other types of supplemental or functional food.. .

Process roducing n-propanol and propionic acid using metabolically engineered propionibacteria

A method is provided for making a banana or plantain product comprising providing at least one unpeeled banana or plantain comprising banana or plantain peel and banana or plantain pulp, subjecting the at least one unpeeled banana or plantain to a heat treatment at a temperature and for a time sufficient to gelatinize starch present in the at least one unpeeled banana or plantain to form at least one heat treated unpeeled banana or plantain, and comminuting the at least one heat treated unpeeled banana or plantain to form a banana or plantain puree. A functional food ingredient is also provided comprising a banana or plantain puree including banana or plantain pulp and optionally banana or plantain peel.
Pepsico, Inc.



Functional Food topics:
  • Functional Food
  • Liver Diseases
  • Liver Disease
  • Fatty Liver
  • Side Effects
  • Atherosclerosis
  • Neurological
  • Bee Pollen
  • Triglycerides
  • Circulatory System
  • Antioxidant
  • Isoflavone
  • Active Principle
  • Isoflavones
  • Principles


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Functional Food for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Functional Food with additional patents listed. Browse our RSS directory or Search for other possible listings.


    1.8621

    file did exist - 2598

    2 - 1 - 51